2021 AISF_SIN意见书：肝肾疾病

2021-06-01 意大利肝病学会 Dig Liver Dis.2021 Jun;53 Suppl 2:S49-S86.

2021年6月，意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下，肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。

中文标题：

英文标题：

Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)

发布机构：

意大利肝病学会

发布日期：

2021-06-01

简要介绍：

2021年6月，意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下，肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。内容涉及慢性肝病患者肾脏损伤的诊断，肝硬化急性肾损伤，慢性肝病与慢性肾病的关系，不同病因的肝病对于肾脏的损害，多囊肾病和肝病。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=cac521c00211a204, title=2021 AISF_SIN意见书：肝肾疾病, enTitle=Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN), guiderFrom=Dig Liver Dis.2021 Jun;53 Suppl 2:S49-S86., authorId=0, author=, summary=2021年6月，意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下，肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。, cover=https://img.medsci.cn/2021623/1624435471488_2020535.jpg, journalId=0, articlesId=null, associationId=487, associationName=意大利肝病学会, associationIntro=意大利肝病学会致力于肝病研究，官方杂志《Digestive and Liver Disease》, copyright=0, guiderPublishedTime=Tue Jun 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月，意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下，肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。内容涉及慢性肝病患者肾脏损伤的诊断，肝硬化急性肾损伤，慢性肝病与慢性肾病的关系，不同病因的肝病对于肾脏的损害，多囊肾病和肝病。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=113039, tagName=肝肾疾病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=6634, guiderKeyword=肝脏疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16278, appHits=92, showAppHits=0, pcHits=385, showPcHits=16186, likes=0, shares=4, comments=5, approvalStatus=1, publishedTime=Wed Jun 23 17:23:35 CST 2021, publishedTimeString=2021-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 23 16:04:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Tue Jan 02 21:51:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AISF_SIN意见书：肝肾疾病.pdf)])

2021 AISF_SIN意见书：肝肾疾病.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错，好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
2021-10-15 鸿毳沉舟

有用

78 0
[GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错，好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
2021-09-16 936368183

不错，好用

83 0
[GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错，好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
2021-09-10 ms5000001604660080

收藏

89 0
[GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错，好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
2021-07-12 一缕阳光 Lee

很好，实用

85 0
[GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错，好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
2021-06-29 李曌

好

80 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化指南

2021 AISF_SIN意见书：肝肾疾病

拓展阅读

科室

工具

服务